Ibrance - Drug Details
๐Ÿ“Š Estimates Ibrance Dialyzability By Different_Modalities

Ibrance

Complete Drug Information

Drug Name
Ibrance
Trade Names
Ibrance
Pregnancy Category
AU: D
Bioavailability
46%
Routes of Administration
Oral
Protein Binding
85%%
Metabolism
Liver (CYP3A, SULT2A1, glucuronidation)
Elimination
29 (ยฑ5) hours
Excretion
74% feces, 18% urine
Formula
C24H29N7O2
Molar Mass
447.543
Volume of Distribution
C24H29N7O2

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.